IP Library Granted Patent US 7,049,441
Granted Patent B2
US 7,049,441 · App. 10/939,293 · Granted May 23, 2006

Process for preparation of benzylpiperidine compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,441
App. No.
10/939,293
Granted
May 23, 2006
Kind
B2
Abstract

According to the process as shown in the following scheme having a step for reacting Compound (I) with Compound (II) to produce Compound (III), benzylpiperidine compounds useful as synthesis starting materials of pharmaceutical agents, agricultural chemicals and the like can be produced conveniently by a short step: wherein R 1 is a hydrogen atom or an amino-protecting group, R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents, and R 3 is a lower alkyl group.

Claims (59)

1. A process for the preparation of a compound represented by the formula:

wherein

R 1 is a hydrogen atom or an amino-protecting group and

R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents,

or a salt thereof, which comprises reacting a compound represented by the formula:

wherein R 3 is a lower alkyl group and R 2 is as defined above, or a salt thereof, with a compound represented by the formula:

wherein R 1 is as defined above, or a salt thereof.

2. A process for the preparation of a compound represented by the formula:

wherein

R 1 is a hydrogen atom or an amino-protecting group and

R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents,

or a salt thereof, which comprises reacting a compound represented by the formula:

wherein X 1 is a halogen atom and R 2 is as defined above, or a salt thereof, with a trialkyl phosphite represented by the formula:

(R 3 O) 3 P  (V)

wherein R 3 is a lower alkyl group, and thereafter reacting with a compound represented by the formula:

wherein R 1 is as defined above, or a salt thereof.

3. The process of claim 2 , wherein the compound represented by the formula (IV) or a salt thereof is reacted with the trialkyl phosphite represented by the formula (V) to give a compound represented by the formula:

wherein

R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents, and

R 3 is a lower alkyl group,

or a salt thereof.

4. A process for the preparation of a compound represented by the formula:

wherein

R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents,

or a salt thereof, which comprises:

reacting a compound represented by the formula:

wherein X 1 is a halogen atom and X 2 is a leaving group, with a compound represented by the formula:

R 2 NH 2   (VII)

wherein R 2 is as defined above, or a salt thereof, to give a compound represented by the formula:

wherein R 2 and X 1 are as defined above, or a salt thereof;

reacting the compound represented by the formula (IV) or a salt thereof with a trialkyl phosphite represented by the formula:

(R 3 O) 3 P  (V)

wherein R 3 is a lower alkyl group;

thereafter reacting with a compound represented by the formula:

wherein R 1 is a hydrogen atom or an amino-protecting group, or a salt thereof, to give a compound represented by the formula:

wherein R 1 and R 2 are as defined above, or a salt thereof; and

reducing and thereafter where necessary deprotecting the compound represented by the formula(III) or a salt thereof.

5. The process of claim 4 which comprises:

reacting a compound represented by the formula:

wherein X 1 and X 2′ are each a halogen atom, with a compound represented by the formula:

R 2 NH 2   (VII)

wherein R 2 is a hydrogen atom, a hydrocarbon group optionally having substituents, an alkoxy group optionally having substituents or a heterocyclic group optionally having substituents, or a salt thereof, to give a compound represented by the formula:

wherein R 2 and X 1 are as defined above, or a salt thereof;

reacting the compound represented by the formula (IV) or a salt thereof with a trialkyl phosphite represented by the formula:

(R 3 O) 3 P  (V)

wherein R 3 is a lower alkyl group, to give a compound represented by the formula:

wherein R 2 and R 3 are as defined above, or a salt thereof;

reacting the compound represented by the formula (I) or a salt thereof with a compound represented by the formula:

wherein R 1 is a hydrogen atom or an amino-protecting group, or a salt thereof, to give a compound represented by the formula:

wherein R 1 and R 2 are as defined above, or a salt thereof; and

reducing and thereafter where necessary deprotecting the compound represented by formula (III) or a salt thereof.

6. The process of claim 1 wherein the compound represented by the formula (II) or a salt thereof is reacted in the presence of a base.

7. The process of claim 6 , wherein the base is t-butoxide of an alkali metal.

8. The process of claim 7 , wherein the base is potassium t-butoxide.

9. A compound represented by the formula:

10. The process of claim 2 , wherein the compound represented by the formula (IV) or a salt thereof is reacted with the compound represented by the formula (V) in the presence of alkali metal iodide.

11. The process of claim 2 , wherein the compound represented by the formula (II) or a salt thereof is reacted in the presence of a base.

12. The process of claim 4 , wherein the compound represented by the formula (IV) or a salt thereof is reacted with the compound represented by the formula (V) in the presence of alkali metal iodide.

13. The process of claim 4 , wherein the compound represented by the formula (II) or a salt thereof is reacted in the presence of a base.

Assignments (1)
CHANGE OF NAME Recorded Jun 2, 2005
From: TAKEDA CHEMICAL INDUSTRIES, LTD.
To: TAKEDA PHARMACEUTICAL COMPANY LIMITED
Reel/Frame 018917/0406 →